• UKRAINE: Situation report day 86 (Graphic)
  • FOOD SECURITY: Fertilizer crisis (Graphic DUE May 20, 12:00GMT)
  • SOCCER: Premier League set for dramatic final day (Graphic DUE May 20, 17:00GMT)
  • SOCCER: Premier League Final Day fixtures, May 22 (Graphic DUE May 20, 17:00GMT)
  • F1: Monaco GP 2022 interactive (Interactive DUE May 20, 18:00GMT)
  • For full details of graphics available/in preparation, see Menu -> Planners
Graphic shows stages in xenotransplantation technology.
GN41918EN

HEALTH

Pig kidney transplanted in human

By Duncan Mil

October 21, 2021 - For the first time, a kidney from a genetically engineered pig has been transplanted into a human without triggering hyperacute rejection by the recipient's immune system.

The surgery carried out on September 25 at NYU Langone Health in New York City involved a brain dead patient on a ventilator with signs of kidney dysfunction, whose family had permitted the three-day experiment for the sake of advancing science.

The researchers kept the pig kidney outside of the patient's body to observe and check it was doing its job during the operation. That is, filtering out waste products from the blood and producing urine.

The kidney made "the amount of urine that you would expect" from a transplanted human kidney, said transplant surgeon Dr Robert Montgomery, who led the study.

Humans and primates differ from other animals in that they lack an enzyme, alpha-gal (alpha 1,3 galactosyltransferase), that places a particular branched sugar group on the animal's cell surfaces.

The kidney was joined to blood vessels on the top of one of the patient's legs so that Montgomery's team could observe it and take biopsy samples.

Montgomery said that the recipient's abnormal creatinine level -- an indicator of poor kidney function -- returned to normal after the transplant.

The genetically modified pig, dubbed GalSafe, was developed by United Therapeutics Corp's Revivicor unit. The U.S. Food and Drug Administration approved it in December 2020 as a potential source of human therapeutics.

Sources
PUBLISHED: 21/10/2021; STORY: Graphic News; PICTURES: NYU Langone Health
Advertisement